Tag Archives: clinical

Family Medicine Wins … or Loses?

Posted on by

Family Medicine Wins or Loses? On the day before graduation at the University of Nevada School of Medicine, where I am Chairman of the Department of Family and Community Medicine, the school recognizes students who have performed well during an awards ceremony Continue reading →

Stem Cell Therapy in India by Revita Life Indian Stem cell Therapy company in India – Video

Posted on by




Stem Cell Therapy in India by Revita Life Indian Stem cell Therapy company in India http://youtu.be/AjE_kTOCBBA Stem Cell Therapy in India by Revita Life Indian Stem cell Therapy company in India Revita Clinical Treatment:Stem Cell Therapy S… By: InternetMarketerInd Continue reading →

European Society of Human Genetics urges caution over use of new genetic sequencing techniques

Posted on by

Public release date: 16-May-2013 [ | E-mail | Share ] Contact: Mary Rice mary.rice@riceconseil.eu European Society of Human Genetics The use of genome-wide analysis (GWA), where the entirety of an individual’s DNA is examined to look for the genomic mutations or variants which can cause health problems is a massively useful technology for diagnosing disease. However, it can also pose major ethical problems if used incorrectly, say new recommendations from the European Society of Human Genetics (ESHG) published on line today (16 May 2013) in the European Journal of Human Genetics. Many services based on whole genome and on exome* sequencing and analysis are now available to patients at an affordable price, and this raises the question of how to ensure that they are provided appropriately Continue reading →

The Future of Healthcare: Artificial Intelligence

Posted on by




The Future of Healthcare: Artificial Intelligence Clinical Support Systems Robert Pearl, CEO of The Permanente Medical Group, explores the idea of using artificial intelligence and clinical support systems to replace traditional, hu… By: stanfordbusiness Continue reading →

NextBio Announces Translational Medicine Partnership with Sanofi

Posted on by

SANTA CLARA, Calif., April 30, 2013 /PRNewswire/ –NextBio today announced a multi-year collaboration with Sanofi (SNY) aimed at using NextBio Clinical to incorporate patient omics and clinical data into Sanofi’s drug research and development, as part of Sanofi’s Translational Medicine for Patients (TM4P) program. (Logo: http://photos.prnewswire.com/prnh/20130402/SF86976LOGO) NextBio will provide Sanofi with the NextBio Clinical platform for aggregation, standardization and analysis of patient clinical data, next generation sequencing (NGS) and other molecular data across public data sources, Sanofi clinical trials and Sanofi hospital partners. NextBio’s unique data integration platform, user interface and real-time Big Data analytics will allow Sanofi biologists and clinicians to tap into a vast, growing collection of patient data as it becomes available, as a key enabling technology for translational and clinical research. Continue reading →

Stanford University School of Medicine Joins zSpace, Inc.'s Academic Advisory Council

Posted on by

SUNNYVALE, CA–(Marketwired – Apr 23, 2013) – zSpace, Inc., a technology provider that is transforming the future of human-computer interaction, announced today that the Stanford University School of Medicine’s Division of Clinical Anatomy has joined the Company’s Academic Advisory Council, a network of universities focused on advancing innovation, design and research. zSpace, Inc., has also joined the Division’s affiliates program as a Premier Affiliate of Clinical Anatomy at Stanford. Through this partnership, Stanford Anatomy will provide constructive input on the continued enhancement of the Company’s flagship product, zSpace, a 3D virtual holographic platform, and use zSpace’s immersive capabilities to advance medical research and education through highly realistic visualization and interaction Continue reading →

Penn researcher wins Distinguished Clinical Research Achievement Award for innovations In gene therapy

Posted on by

A gene therapy study focused on finding a cure for a rare congenital blinding disease has been recognized as one of the ten most outstanding clinical research projects of the year by the Clinical Research Forum (CRF). The study, led by Jean Bennett, MD, Phd, F.M. Kirby professor of Ophthalmology at the University of Pennsylvania School of Medicine, and carried out in collaboration with Penn Medicine’s Albert M. Continue reading →

Penn Medicine gene therapy study receives Distinguished Clinical Research Achievement Award

Posted on by

A gene therapy study focused on finding a cure for a rare congenital blinding disease has been recognized as one of the ten most outstanding clinical research projects of the year by the Clinical Research Forum (CRF). The study, led by Jean Bennett, MD, Phd, F.M. Kirby professor of Ophthalmology at the University of Pennsylvania School of Medicine, and carried out in collaboration with Penn Medicine’s Albert M. Continue reading →

Penn study sheds light on the complexity of gene therapy for congenital blindness

Posted on by

Public release date: 21-Jan-2013 [ | E-mail | Share ] Contact: Katie Delach katie.delach@uphs.upenn.edu 215-349-5964 University of Pennsylvania School of Medicine PHILADELPHIA – Independent clinical trials, including one conducted at the Scheie Eye Institute at the Perelman School of Medicine, have reported safety and efficacy for Leber congenital amaurosis (LCA), a congenital form of blindness caused by mutations in a gene (RPE65) required for recycling vitamin A in the retina. Inherited retinal degenerative diseases were previously considered untreatable and incurable. There were early improvements in vision observed in the trials, but a key question about the long-term efficacy of gene therapy for curing the retinal degeneration in LCA has remained unanswered Continue reading →

Light shed on complexity of gene therapy for congenital blindness

Posted on by

Jan. 21, 2013 Independent clinical trials, including one conducted at the Scheie Eye Institute at the Perelman School of Medicine, have reported safety and efficacy for Leber congenital amaurosis (LCA), a congenital form of blindness caused by mutations in a gene (RPE65) required for recycling vitamin A in the retina. Continue reading →

Simulation-Based Training at Duke-NUS – Video

Posted on by




Simulation-Based Training at Duke-NUS Students undergo an interactive simulation-based learning at the Clinical Performance Center (CPC) in Duke-NUS Graduate Medical School, as part of their clinical training skills program which prepares them for actual clinical practice. This video was produced by the Office of Communications and Development, Duke-NUS Graduate Medical School.From:InsideDukeNUSViews:1 0ratingsTime:05:54More inEducation Continue reading →

Producing Viral Vectors for Clinical Trials With On-Site Clinical Manufacturing Facility – Video

Posted on by




Producing Viral Vectors for Clinical Trials With On-Site Clinical Manufacturing Facility Viral gene therapy is being tested as treatment for numerous diseases, including cancer, cystic fibrosis, heart disease, muscle diseases, diabetes and neurodegenerative disease like Parkinson's. Continue reading →

uniQure Initiates Phase I in Acute Intermittent Porphyria

Posted on by

AMSTERDAM, December 11, 2012 /PRNewswire/ — uniQure B.V., a leader in the field of human gene therapy, today announced the start of its Phase I clinical trial in acute intermittent porphyria (AIP) with the treatment of the first patient. Continue reading →

Springer launches new journal with the Italian Association of Nuclear Medicine and Molecular Imaging

Posted on by

( Springer ) Springer will launch a new journal Clinical and Translational Imaging: Reviews in Nuclear Medicine and Molecular Imaging. Continue reading →